Hong Kong, February 16 (Xinhua): The Hong Kong Advisory Panel on Vaccines Covid-19 decided that Tuesdays recommend the vaccine produced by Sinovac Biotech for emergency use.

Panel experts believe that the Inactivated Sinovac vaccine can provide more benefits than risks and will present their advice to the Special Administrative Region of Hong Kong (HSAR) Government of reference, Wallace Lau, the connoisseur of the panel, said in a press release session.

Panel members reached consensus after reviewing the latest reports offered by SCOVAC at a meeting on Tuesday, he said.

The HKSAR government reached an agreement at the end of last year to obtain 7.5 million doses of the Sinovac vaccine. EndItem

Image of How to find a teaching job in Universities in China
Rate and Comment
Image of Hong Kong's retail sales maintain notable growth in April
Hong Kong's retail sales maintain notable growth in April

Hong Kong, June 1 (Xinhua) - Hong Kong retail sales continued to increase in April thanks to an epidemic of Covid-19. The value of total retailers

Read more →

Login

 

Register

 
Already have an account? Login here
loader

contact us

 

Add Job Alert